相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Aberrant Methylation of RASSF2A in Human Pancreatic Ductal Adenocarcinoma and Its Relation to Clinicopathologic Features
Ling Zhao et al.
PANCREAS (2012)
Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma
Helena Caren et al.
BMC CANCER (2011)
Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumors
Hanna Kryh et al.
BMC GENOMICS (2011)
Neuroblastoma epigenetics From candidate gene approaches to genome-wide screenings
Anneleen Decock et al.
EPIGENETICS (2011)
Epigenetic inactivation of the RASSF10 candidate tumor suppressor gene is a frequent and an early event in gliomagenesis
V. K. Hill et al.
ONCOGENE (2011)
Human RASSF7 regulates the microtubule cytoskeleton and is required for spindle formation, Aurora B activation and chromosomal congression during mitosis
Asha Recino et al.
BIOCHEMICAL JOURNAL (2010)
MicroRNA Mediates DNA Demethylation Events Triggered by Retinoic Acid during Neuroblastoma Cell Differentiation
Sudipto Das et al.
CANCER RESEARCH (2010)
Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences
Undraga Schagdarsurengin et al.
MOLECULAR CANCER (2010)
The RASSF8 candidate tumor suppressor inhibits cell growth and regulates the Wnt and NF-κB signaling pathways
F. E. Lock et al.
ONCOGENE (2010)
High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset
Helena Caren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Embryonal neural tumours and cell death
John Inge Johnsen et al.
APOPTOSIS (2009)
RASSF1A hypermethylation in pretreatment serum DNA of neuroblastoma patients: a prognostic marker
A. Misawa et al.
BRITISH JOURNAL OF CANCER (2009)
NORE1B Is a Putative Tumor Suppressor in Hepatocarcinogenesis and May Act via RASSF1A
Doris Macheiner et al.
CANCER RESEARCH (2009)
NORE1A Tumor Suppressor Candidate Modulates p21CIP1 via p53
Diego F. Calvisi et al.
CANCER RESEARCH (2009)
Frequent epigenetic inactivation of RASSF10 in thyroid cancer
Undraga Schagdarsurengin et al.
EPIGENETICS (2009)
The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias
Luke B. Hesson et al.
MOLECULAR CANCER (2009)
SnapShot: Ras signaling
Megan Cully et al.
CELL (2008)
Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma
Janos Geli et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
RASSF7 is a member of a new family of RAS association domain-containing proteins and is required for completing mitosis
Victoria Sherwood et al.
MOLECULAR BIOLOGY OF THE CELL (2008)
Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer
W. N. Cooper et al.
ONCOGENE (2008)
Genetic and epigenetic changes in the common Ip36 deletion in neuroblastoma tumours
H. Caren et al.
BRITISH JOURNAL OF CANCER (2007)
Ras-association domain family protein 6 induces apoptosis via both caspase-dependent and caspase-independent pathways
Mitsunobu Ikeda et al.
EXPERIMENTAL CELL RESEARCH (2007)
Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma
Zhe Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma
Paula Lazcoz et al.
BMC CANCER (2006)
Identification of RASSF8 as a candidate lung tumor suppressor gene
F. S. Falvella et al.
ONCOGENE (2006)
RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer
M Endoh et al.
BRITISH JOURNAL OF CANCER (2005)
The RASSF1A isoform of RASSF1 promotes microtubule stability and suppresses tumorigenesis
L van der Weyden et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer
K Akino et al.
GASTROENTEROLOGY (2005)
CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations
LB Hesson et al.
ONCOGENE (2005)
BiSearch: primer-design and search tool for PCR on bisulfite-treated genomes
GE Tusnady et al.
NUCLEIC ACIDS RESEARCH (2005)
Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastoma
QW Yang et al.
CLINICAL CANCER RESEARCH (2004)
RASSF4/AD037 is a potential ras effector/tumor suppressor of the RASSF family
K Eckfeld et al.
CANCER RESEARCH (2004)
The t(1;3) breakpoint-spanning involved in clear cell renal cell genes LSAMP and NORE1 are carcinomas
JD Chen et al.
CANCER CELL (2003)
Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma
MR Morris et al.
ONCOGENE (2003)
RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor
MD Vos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Neuroblastoma: Biological insights into a clinical enigma
GM Brodeur
NATURE REVIEWS CANCER (2003)
NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers
L Hesson et al.
ONCOGENE (2003)
The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1
S Ortiz-Vega et al.
ONCOGENE (2002)
RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours
D Astuti et al.
ONCOGENE (2001)
Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN
T Teitz et al.
NATURE MEDICINE (2000)
分享论文
